China Gains WHO PreQ For Circumcision Device, Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
China has obtained the first WHO prequalification for an innovative device for male circumcision, Shangring, along with a flu vaccine. Could the two high-profile recognitions in a month herald a new crop of high quality, made in China health products inching toward the world stage?
You may also be interested in...
WHO’s Chan Outlines ‘Chinese Dream’ For Health Care Reforms
Relying on general practitioners instead of hospitals and increasing compensation to physicians can solve many health care reform issues in China, says the world's top public health official, who also discusses vaccine scandal in China and Zika infection risks during Rio Olympics.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.